What's new

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 1, Status: Authorised

Mar 3, 2025 - 17:37
 0
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Protagonist says Takeda-partnered drug succeeds in rare blood cancer

Next Article

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab,...

Related Posts

PSUSA/00010252/202406

PSUSA/00010252/202406

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Dafiro, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Quality Working Party

Quality Working Party

Feb 9, 2025  0